Trump Urges Pharma Companies to Justify COVID Drug Success

President Trump has publicly called on pharmaceutical companies, including Pfizer, to justify the effectiveness of their COVID-19 drugs, expressing skepticism about the transparency of their data. He emphasized the importance of these companies sharing their results with both the public and the Centers for Disease Control and Prevention (CDC) to resolve ongoing disputes about the drugs' success. This demand for clarity comes amid internal turmoil at the CDC, including the dismissal of CDC Director Susan Monarez, who opposed vaccine policy changes proposed by Health Secretary Robert F. Kennedy Jr. These policy changes would limit access to COVID-19 vaccines and have drawn criticism from health officials. Trump also questioned whether Operation Warp Speed, the federal program that accelerated vaccine and drug development, was as successful as widely claimed. He urged the pharmaceutical companies and health authorities to clear up the confusion and provide definitive answers about the COVID-19 drugs' impact on saving lives.